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For many diseases with a foetal origin, the cause for the disease initiation remains unknown. Common 
childhood acute leukaemia is thought to be caused by two hits, the first in utero and the second in 
childhood in response to infection. the mechanism for the initial DNA damaging event are unknown. 
Here we have used in vitro, ex vivo and in vivo models to show that a placental barrier will respond 
to agents that are suspected of initiating childhood leukaemia by releasing factors that cause DNA 
damage in cord blood and bone marrow cells, including stem cells. We show that DNA damage caused 
by in utero exposure can reappear postnatally after an immune challenge. Furthermore, both foetal 
and postnatal DNA damage are prevented by prenatal exposure of the placenta to a mitochondrially-
targeted antioxidant. We conclude that the placenta might contribute to the first hit towards leukaemia 
initiation by bystander-like signalling to foetal haematopoietic cells.
For an increasing number of adult and childhood diseases, the evidence points to a foetal origin1–3. In the case of 
common childhood acute leukaemia, the ‘two-hit hypothesis’ proposes that a pre-leukaemic state is established 
in utero, characterised by DNA damage to haematopoietic stem or progenitor cells in the form of chromosomal 
translocations or aneuploidy4–6. This initiating event predisposes to overt leukaemia, following a second genetic 
hit during childhood that has been linked to an aberrant response following (delayed encounter of) common 
infection7–9. Childhood leukaemia is the most common paediatric malignancy, and the incidence is steadily rising 
in developed countries10,11. The in utero origin of common childhood acute lymphocytic leukaemia (cALL)12–16, 
and to some extent acute myeloid leukaemia (AML), has been well documented using twin studies and retrospec-
tive scrutiny of patients’ neonatal blood spots16–18. However, the causes for the DNA damage in foetal haemato-
poietic cells required for the initiating event, remain enigmatic.
Certain epidemiological studies report a link between maternal exposure during pregnancy and an increased 
risk of childhood leukaemia in the offspring (summarised in Table 1).
Although these epidemiological studies are informative, they are troubled by contradictory results, low study 
numbers, recall bias due to their retrospective nature and socio-economic, environmental and genetic factors that 
influence the results. Experimental evidence is required to bridge the gap between these epidemiological studies 
and clinical observations. To establish such an experimental model, three factors need to be initially investigated: 
the ‘trans-generational’ effect of maternal exposure agents that have been linked with increased leukaemia risk in 
offspring, the role of the barrier between mother and foetus and the nature of DNA damage in the foetal blood.
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In this study, DNA damage in cord blood and bone marrow is quantitatively and qualitatively described, 
using chromatin lesions or recruited DNA repair proteins, including phosphorylated histone H2AX (γ-H2AX) to 
mark double strand breaks, Fanconi Anemia Complementation Group D2 (FANCD2) to mark DNA cross-links, 
KU70 and KU80 which are involved in non-homologous end joining (NHEJ), Replication Protein 32 kDa subunit 
(RPA32) which is recruited during homologous recombination, X-ray Repair Cross-Complementing protein 1 
(XRCC1) to mark single-strand breaks, and p53 Binding Protein 1 (53BP1) as a generic DNA damage sensor. 
Following the DNA damage, the cell must survive, without full recovery of its DNA damage by means of DNA 
repair, and have or obtain clonogenic potential, for it to establish a pre-leukaemic clone.
The interface between mother and foetus during pregnancy, the placenta, plays a key role in foetal program-
ming19,20. Specifically, the barrier between maternal and foetal blood in the placenta is established by trophoblast 
cells. During the first trimester, a bilayer of trophoblast lines the chorionic villi of the placenta that bathe in a pool 
of maternal blood21. Foetal-maternal transport takes place across this trophoblast barrier. We have previously 
shown that some agents (nanoparticles, altered oxygen and pharmacological inhibition of the electron transport 
chain), which cause oxidative stress to the trophoblast barrier, will also cause it to release factors that induce 
DNA damage in cells on the opposite side of the exposed surface of the barrier22–26. In these previous studies, the 
chemicals that are associated with leukaemia (see Table 1) and the effects of radiation and mimics of infections 
were not studied.
We have also previously shown in mice that intravenous injection of a mitochondrial antioxidant, mitoquinol 
(MitoQ), attached to a drug delivery nanoparticle, allows the antioxidant to enter the placental barrier without 
reaching the foetus, and not only prevent oxidative stress in the placenta and placental secretions, as caused by 
maternal hypoxia, but also prevent altered foetal brain and cardiovascular development26. Considering that some 
of the suggested leukaemia-initiating agents also cause oxidative stress27,28, we hypothesised that such agents 
might cause the barrier to release factors that cause DNA damage and/or chromosome aberrations in cord blood 
cells, used here to model foetal haematopoietic cells. Current thinking might suggest that chemicals pass through 
the placental barrier to reach the foetus and so damage the blood by a direct exposure. We have examined here 
whether they might instead, or as well, damage the foetal blood indirectly, by initiating DNA damaging signalling 
between the placenta and the foetal blood. We have used in vitro, ex vivo and in vivo models of the placenta to 
simulate what might occur during establishment of DNA damage in the developing foetal haematopoietic system, 
and we have tested the efficacy of a nanoparticle-bound antioxidant in preventing DNA damage. We have shown 
that the placenta can release DNA damaging factors in response to chemical and radiation exposure, to which 
blood cells are selectively sensitive. This lesion could represent an initiating hit, in the sense that the DNA damage 
is enhanced after a ‘secondary hit’, in the form of an induced inflammatory response, using our in vivo model. 
Administration of MitoQ -bound nanoparticles to the mother during pregnancy, or to the placental barrier in 
culture, prevented this DNA damage.
Results
Differential DNA damage response between fibroblasts and cord blood exposed to tropho-
blast conditioned media in vitro. We first tested whether a simple in vitro model of the placental barrier 
would release a DNA damaging factor if it was exposed to agents that may cause leukaemia. A bilayered barrier 
of BeWo trophoblast cells resting on transwell inserts was used as the placental barrier model25,29. The top surface 
of the barrier was exposed for 24 hours to the putative leukaemic agents and the tissue culture media below the 
barrier (conditioned media, CM) was collected. Human fibroblasts were then exposed for 24 hours to the condi-
tioned media, using the fibroblasts as a standard cell type23,25 with which to measure the amount of DNA damage 
induced by factors released into the conditioned media. We compared the damage caused by conditioned media 
in fibroblasts to the damage recorded in umbilical cord blood cells in an identical set up. The increase in DNA 
damage was recorded using the alkaline comet assay (Fig. 1I) to detect single and double strand breaks and alka-
line labile sites, and γ-H2AX as a marker of DNA double strand breaks (Fig. 1J). The conditioned media below 
barriers exposed to Cr (VI) ions (Fig. 1A), lipopolysaccharide (LPS) (a potent immunostimulant found in the cell 
wall of Gram negative bacteria) and polyinosine-polycytidine (PolyI:C) (a synthetic double-stranded RNA that 
mimics viral infection) (Fig. 1C), and etoposide (a chemotherapeutic agent that acts by inhibiting DNA topoi-
somerase II) (Fig. 1G) all caused significant DNA damage in human fibroblasts. Previous research using the same 
concentration of Cr (VI) ions (0.4 μM) showed that only a small concentration of Cr (VI) ions passed through the 
Maternal exposure agent Strength of link References
Chromium ~ 58–60
Hypoxia ~ 61,62
Infection +/− 63–70
DNA topoisomerase II 
inhibitors +/−
71–75
Pesticides + 30,76–80
Benzene ++ 81–84
Ionising radiation +++ 30–33,82
Table 1. Summarised overview of maternal exposures that are investigated, and the strength of their 
association, with leukaemia. *~Infrequently reported and mixed results; +/−frequently investigated and 
mixed results, +frequently positively associated; ++frequent and consistent evidence reported, +++proven 
association.
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Figure 1. Differential DNA damage response between fibroblasts and cord blood after exposure to conditioned 
media from BeWo barriers. The level of DNA damage in fibroblasts as recorded by either the mean tail moment, 
using the alkaline comet assay (A–F), or immunocytochemical analysis of the mean number of γ-H2AX foci 
per cell (DNA double-strand breaks). (G,H) Values are shown for fibroblasts (left hand column) and umbilical 
cord blood (UCB) mononuclear cells (right hand column) after a 24 hour exposure to conditioned media below 
BeWo barriers resting on transwell inserts. The top surface of BeWo barriers was exposed to culture media 
without (open histograms) or with (shaded histograms) (A,B) 0.4 uM Cr(VI); (C,D) LPS or PolyI:C (ng/ml); 
(E,F) altered levels of oxygen; (G,H) etoposide (0.1, 1, 10 and 100 μM). Representative images of (I) comet assay 
and (J) γ-H2AX immunostaining are shown. Plots represent the mean ± SD of 3 independent experiments. 
n = 3. *p < 0.05, **p < 0.01, ***p < 0.001 as determined by unpaired two-tailed student’s t-test.
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bilayered BeWo barrier and that this was too low to cause DNA damage in fibroblasts23. This suggested that the 
damage was due to release of DNA-damaging agents from the barrier rather than a passage of Cr(VI) across the 
barrier and into the conditioned medium. To explore this possibility further, we exposed the barriers to hypoxia 
followed by reoxygenation, inducing a hypoxia response, validated by increased protein level of hypoxia- induci-
ble factor 1-alpha (Fig. S1). Here, no chemical would be present to pass through a barrier. Nonetheless, the condi-
tioned media caused DNA damage in fibroblasts (Fig. 1E). This points to a DNA damaging factor being released 
by the barrier, rather than an exposing agent passing through the barrier to damage the fibroblasts directly. We 
tested whether human cord blood mononuclear cells would also be damaged by these factors. Surprisingly, and 
unlike fibroblasts, there was no increased DNA damage in human cord blood cells that had been exposed to con-
ditioned media below barriers whose top surface had been exposed to Cr (VI) (Fig. 1B), PolyI:C or LPS (Fig. 1D), 
altered oxygen levels (Fig. 1F) or etoposide at several doses (Fig. 1H).
This suggests that there is a DNA damaging factor which is released by the placental barrier in vitro in response 
to certain agents, to which fibroblasts are sensitive and cord blood cells are not.
DNA damage in cord blood after indirect exposure to leukaemogenic agents in vitro. To assess 
if this differential response between cord blood and fibroblasts holds true for leukaemic agents, we exposed BeWo 
barriers to agents that have been linked more extensively and more convincingly to leukaemia initiation: pes-
ticides, benzene and radiation (see Table 1). Similar to the experiments discussed in Fig. 1, DNA damage was 
measured in cord blood and fibroblasts after in vitro exposure to BeWo collected media. The conditioned media 
below barriers exposed to piperonyl butoxide and pyrethroid (a common pesticide formula) (Fig. 2A), and ben-
zoquinone (BQ) and hydroquinone (HQ) (benzene metabolites) (Fig. 2C), caused significant DNA damage in 
fibroblasts. Using Selective Ion Monitoring (SIM) in our study, we found no evidence of hydroquinone or benzo-
quinone in the conditioned media below the barrier after exposure of these chemicals above the barrier (Fig. S2). 
In addition, the integrity of BeWo cell barriers was measured by trans-epithelial electrical resistance (TEER) (data 
not shown) and by testing the endothelial permeability to FITC-BSA (Fig. S3) and no evidence of a change in per-
meability or electrical resistance was observed. This is also in keeping with a DNA damaging factor that is released 
from BeWo cell barriers. However, unlike the previous exposures (Fig. 1), here there was a significant increase in 
DNA damage in cord blood cells, as well as fibroblasts, if they were exposed to condioned media below barriers 
whose top surface had been exposed to pesticides (Fig. 2B), and benzoquinone with or without hydroquinone 
(Fig. 2D). The cord blood cells also showed increased DNA damage if they were directly exposed to irradiation 
(Figs 2H and S4), in keeping with the literature that singles out radiation as a known cause for leukaemia30–33. 
Together, these findings suggest that human cord blood cells are selective in their response to the DNA damaging 
factors in the conditioned medium.
A comparison was made of the protective effect of the antioxidant N-acetyl cysteine (NAC) on the signalling 
of barriers exposed to benzoquinone and hydroquinone to both fibroblasts and cord blood. Applying N-acetyl 
cysteine either to barriers (B) (Fig. 2C,D) or directly to the cells (C) (Fig. 2C,D) that were exposed to the condi-
tioned medium, partly reduced the DNA damage in fibroblasts (Fig. 2C) but completely abolished the damage 
in cord blood cells (Fig. 2D) suggesting that there might be a second (non-oxidative) molecule that was released 
from BeWo barriers that would damage fibroblasts but not cord blood cells. In addition, there was a different pat-
tern of DNA damage in fibroblasts (Fig. 2E) compared to cord blood cells (Fig. 2F) after exposure to conditioned 
medium below hydroquinone and benzoquinone exposed barriers. Although there was a significant increase 
in γ-H2AX, 53BP1 and FANCD2 in both fibroblasts and cord blood cells, the levels of RPA32, Ku70 and Ku80 
were only elevated in fibroblasts (see also Fig. 2G). This suggests that cord blood cells differ in their DNA damage 
response from fibroblasts, displaying a more selective reponse to exposures and a more restricted DNA damage 
pattern.
Numerical and structural cytogenetic analysis after indirect exposure of cord blood mononu-
clear cells to benzene metabolites and pesticides. Having seen DNA strand breaks in cord blood 
cells, it was of interest to see whether this might be accompanied by an increase in cytogenetic abnormalities. 
The commonest karyotypic abnormalities in childhood leukaemia are charaterised by hyperdiploidy (35%) or 
ETV6/RUNX1 fusion (25%), which are mutually exclusive events6. Another 6% of cases is characterised by hypo-
diploidy34. The karyotypic abnormality is a strong predictor of the survival of the patient: hypodiploidy having a 
worse prognosis than hyperdiploidy or ETV6/RUNX1 fusion.
Indirect exposure to benzoquinone and hydroquinone across the BeWo barrier led to a significant increase in 
numerical chromosome aberrations in metaphases in the short- (1 day) and medium-term (6 days) after a single 
24 hour exposure to the conditioned medium from below the barrier (Fig. 3A). There was a significant increase of 
hypodiploidy one day after exposure and a significant increase of hyperdiploidy 6 days after exposure. The mitotic 
rate (measured as the number of metaphases per slide) remained similar to control levels (Fig. 3A). Indirect 
exposure to pesticides across the barrier also caused a significant increase of chromosome aberrations, specifically 
hypodiploidy measured after 6 days. There was a greater frequency of metaphases in which the chromosomes 
were clumped together with nuclear membranes being faintly present 6 days after indirect exposure to pesticide 
(Fig. 3B,C). This could indicate failure of nuclear envelope breakdown and will hinder cell cycle progression, 
which could have caused the subsequent drop in mitotic rate. Further examples of abnormal chromosome mor-
phology after indirect exposure included triradial, quadriradial, and dicentric chromosomes, double chromatid 
breakage, satellite-associated chromosomes, and chromatid exchange between two different chromosomes after 
exposure to the conditioned medium (Fig. 3D,F). To check for genetic lesions that are not involved in leukaemia 
initiation, telomeric fusion events were analysed. There was no evidence of end-to-end joining in the form of 
telomere fusions, when measured using single telomere length analysis (STELA) (Fig. S5).
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Figure 2. DNA damage in cord blood and fibroblasts after exposure to conditioned media from BeWo barriers 
treated with leukaemogenic agents. The level of DNA damage as recorded by either the mean tail moment, using 
the alkaline comet assay (A–D), or immunocytochemical analysis of the mean number of γ-H2AX foci per cell 
(DNA double-strand breaks) (E,F,H), together with the mean number of foci per cell of 53 BPI (DNA double-
strand breaks), FANCD2 (DNA interstrand crosslinks), RPA32 (homologous recombination), XRCC1 (DNA 
single-strand breaks), Ku70 and Ku80 (non-homologous end joining) (E,F). Representative images of these 
markers are shown (G). Values are shown in for fibroblasts (left hand column) and umbilical cord blood (UCB) 
mononuclear cells (right hand column) after a 24 hour exposure to conditioned media below BeWo barriers 
resting on transwell inserts. The top surface of BeWo barriers was exposed to culture media without (open 
histograms) or with (shaded histograms) (A,B) pesticide comprising of pyrethroids with piperonyl butoxide 
(1.3 µg/ml, 13 µg/ml, 130 µg/ml and 1300 µg/ml); (C,D) benzene metabolites consisting of benzoquinone (BQ, 
30 μM) with or without hydroquinone (HQ, 30 µM) with or without the antioxidant N-acetyl cysteine (NAC, 
10 mM) which was either applied to the barrier (‘B’) or to the fibroblast or cord blood cells directly (‘C’); 
(E,F) benzoquinone (BQ, 30 μM) and hydroquinone (HQ, 30 μM); (H) The level of DNA damage in UCB 
cells is shown after direct exposure to X-irradiation (2 Gy). Plots represent the mean ± SD of 3 independent 
experiments. n = 3. *p < 0.05, **p < 0.01, ***p < 0.001 as determined by unpaired two-tailed student’s t-test.
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Despite the levels of DNA damage and cytogenetic abnormalities, the cord blood cells exposed to CM from 
benzene or pesticides did not show altered colony forming potential (Fig. S6) or major changes in lineage output 
(Fig. S7). This suggests that the majority of stem/progenitor cells retained their functionality.
Collected media from placentae exposed in vivo can send a DNA damage signal to neonatal 
bone marrow cultured ex vivo. We next tested whether the placenta might be able to send a DNA damag-
ing signal if the mother was exposed in vivo to an agent known to be associated with increased risk of leukaemia. 
Pregnant mice were exposed at gestational day (GD) 12 to either 0.1 or 1 Gy of whole body X-irradiation, sacri-
ficed 4 hours later and the placentae were removed. Each placenta was placed into tissue culture media with or 
without an antioxidant treatment for 24 hours to condition the culture media. Because some of the experiments 
that follow were done in vivo, we used the antioxidant MitoQ bound to nanoparticles as a convenient way of 
treating the placenta and not the foetus35, which has not yet been achieved with N-acetyl cysteine. A 24 hour ex 
vivo exposure of mouse bone marrow cells (from 4 week old mice) to the conditioned media caused an increase 
in DNA damage, including double strand breaks (γ-H2AX and 53BP1 foci) and DNA cross-links (FANCD2) 
(Fig. 4A,B). This confirmed that DNA damaging factors are released by a placenta exposed to radiation in vivo, to 
which haematopoietic cells are responsive. In a subsequent experiment, pregnant mice were exposed to HQ (only, 
as BQ is metabolised from HQ in vivo) at GD12 for 24 hours through oral gavage, with or without an intravenous 
Figure 3. Cytogenetic analysis of mononuclear cord blood cells after exposure to conditioned media below 
BeWo barriers exposed to benzene metabolites and pesticides. Numerical (A) and structural (B,C) analyses 
of metaphase spreads from cord blood cells at 1, 6 and 11 days after a 24 hour exposure to the conditioned 
media below BeWo barriers, whose top surface had been exposed to plain cell culture media (control), either 
30 μM hydroquinone and 30 μM benzoquinone (30 μM BQ + HQ) or 100 μg/ml pyrethroids with piperonyl 
butoxide for 24 hours (100 μg/ml pesticides). (A) Percentage of metaphase spreads with 46 (normal), less than 
46 (hypodiploid) or more than 46 (hyperdiploid) chromosomes (histograms) and number of metaphases 
per slide (lines). (B) Percentage of metaphases in which chromosomes were well spread (normal) or 
clumped together, and number of metaphases per slide (lines). Histograms represent mean and SD (n = 4). 
(C) Representative metaphase spreads displaying chromosome clumping. (D–F) Representative abnormal 
chromosomal events, taken one day after exposure to conditioned media (CM) below benzene or pesticide 
exposed BeWo barriers: (D) Metaphase containing numerous structural chromosome abnormalities, the most 
striking of which are: (i) Tri-radial chromosome as a result of chromatid interchange; (ii) Fusion between two 
chromosomes; (BQ + HQ) (E) Metaphase spread with (i) Quadri-radial chromosome; (ii) asymmetrical tri-
radial chromosome; (iii) two examples of double chromatid breakage and (vi) Satellite associated chromosome 
(pesticide) (F) Metaphase spread with (i) two examples of satellite association chromosomes; (ii) Chromatid 
exchange between two different chromosomes; (iii) Two examples of di-centric chromosomes (pesticide). Plots 
represent the mean ± SD. n = 3. *p < 0.05, ***p < 0.001 as determined by unpaired two-tailed student’s t-test.
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injection of the MitoQ nanoparticles. Again, the placentae were removed (six days later, at GD18) and placed in 
tissue culture media for 24 hours to condition the culture media. This conditioned media caused an increase in 
markers of DNA damage and cross-linkage in mouse bone marrow cells after a 24 hour exposure (Fig. 4C). In 
both experiments, after maternal exposure to radiation or to HQ, the MitoQ nanoparticles reduced the level of 
DNA damage (particularly 53BP1) and cross-linkage in the mouse bone marrow cells. No HQ was detected in the 
conditioned media after in vivo injection. In view of this, and because irradiation would not have been retained in 
the placenta to leak into the tissue culture conditioned media, we can conclude that the placenta can send a DNA 
damaging signal if it is exposed in vivo to an agent that is associated with a risk of leukaemia and that this can be 
prevented by means of antioxidant treatment.
Maternal hydroquinone exposure causes damage to foetal bone marrow in vivo that is rein-
stated after immunostimulation during the equivalent of early childhood. Subsequently we 
examined whether the mononuclear cells in the bone marrow of the foetus (GD18) would be damaged in vivo, 
if the mother had been exposed to HQ through oral gavage at GD12, with or without a concurrent intravenous 
injection of MitoQ nanoparticles. In our previous experiments we showed that these MitoQ nanoparticles would 
prevent increased oxidative stress in the placenta but not reach the foetus35. The results showed that, like the ex 
vivo experiments (Fig. 4), there were significant increases in markers of DNA damage as indicated by γ-H2AX, 
53BP1 (Fig. 5A,C), FANCD2 (Fig. 5E) and Ku80 foci (Fig. 5G) and that this could be prevented or was no longer 
apparent after the intravenous injection of nanoparticle-bound antioxidant.
Having established that the foetal bone marrow could be damaged in vivo by a single maternal exposure to the 
benzene metabolite and prevented by maternal injection of antioxidant, we next explored whether this damage 
had the potential to act as a first hit in that it might be altered or augmented by a second hit occurring postnatally. 
In order to explore this, we repeated the in vivo experiments but this time kept the offspring from the exposed 
mother until 4 weeks postnatally. The offspring were then given an intraperitoneal injection of PolyI:C to mimic a 
second hit in the form of a viral infection in early childhood and examined 4 days later. In these experiments, the 
bone marrow of the offspring without PolyI:C treatment (labelled as HQ) no longer showed overall increase in 
DNA damage (Fig. 5B,D), cross-linkage (Fig. 5F) or non-homologous end joining (Fig. 5H), suggesting that the 
damage had been mostly repaired. Strikingly though, if the offspring were exposed to the viral mimic (HQ + PI), 
there were increased double strand breaks (Fig. 5B,D) and cross-links (Fig. 5F) in the bone marrow cells. The 
increase of double strand breaks was prevented by the maternal exposure to antioxidant nanoparticles during 
pregnancy and was not seen after PolyI:C treatment at 4 weeks without prior exposure to HQ during pregnancy 
(PI). We therefore conclude that this intrauterine exposure during pregnancy, whose effect can be prevented by 
the maternal exposure to nanoparticle-bound antioxidant, has a feature of a first hit in that it can be revitalized or 
augmented or made effective by a relevant second hit during the equivalent of early childhood.
Figure 4. Ex vivo model of placental signalling and its contribution to DNA damage signal propagation using 
γ-H2AX, 53BP1 and FANCD2 as DNA damage markers. (A,B) The placentae were removed from mice that 
were exposed to 0.1 or 1 Gy X-irradiation at GD12 or to (C) hydroquinone (at GD12) (50 mg/kg body weight 
in H2O) by oral gavage. Bone marrow cells from age-matched female C57Bl/6J were exposed for 24 hours in 
vitro to conditioned media. This conditioned media was generated by bathing the placentae for 24 hours in fresh 
culture medium, with or without addition of MitoQ-bound nanoparticles (MQ, 0.5 μM). The bone marrow cells 
were then screened for the level of DNA damage. Four placentae were used per mouse. Four mice per condition 
were investigated. n = 4. *p < 0.05, **p < 0.01 and ***p < 0.001, compared to untreated controls (unpaired 
two-tailed student’s t-test).
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Figure 5. The effects of maternal exposure to hydroquinone ± MitoQ-bound nanoparticles, with or without 
postnatal exposure to PolyI:C, on DNA damage in the bone marrow of the offspring. Pregnant mice were 
exposed to vehicle (H2O) (control, open histograms), hydroquinone (HQ) or hydroquinone and MitoQ 
nanoparticles (HQ + MQ) (shaded histograms) at GD12 and the level of DNA damage was measured in bone 
marrow cells from the offspring at delivery (GD18, left hand column) or at 4 weeks + 4 days postnatally (right 
hand column), with (+PI) or without an exposure of the offspring to PolyI:C at 4 weeks postnatally. Graphs 
show the mean ± SEM number of foci per cell of γ-H2AX (A,B), 53BPI (C,D), FANCD2 (E,F) and Ku80 (G,H). 
Four placentae were used per mouse and 4 mice were investigated per condition. n = 4 *p < 0.05, **p < 0.01, 
***p < 0.001 as determined by unpaired two-tailed student’s t-test.
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Figure 6. Assessment of DNA damage in the stem and progenitor cell compartment. CD34+ cord blood cells 
were FACS sorted after a 24 hour exposure to plain BeWo CM (control) or from BQ + HQ exposure (30uM 
BQ+HQ). Metaphase spreads indicate numerical chromosome abnormalities in CD34+ cells three days after 
exposure (A). Flow cytometric analysis of γ-H2AX staining within proliferating (ki-67+) CD34+ and CD34− 
fractions (B). Colony forming unit assay of CD34+ cells plated one day after exposure (C). Pregnant females 
were injected with either vehicle (H2O) or hydroquinone at GD12. Mean γ-H2AX foci in HSCs that were 
taken from pups and induced to proliferate with IL-1 without PolyI:C treatment (D). The pups were injected 
with PolyI:C 4 weeks after birth and their BM harvested 4 days later for examination of the mean number of 
γ-H2AX foci in lymphoid and myeloid cells (E), HSC frequency within the BM (Lin−/Sca1+/ckit+/Flk2−/
CD48−/CD150+) (F), myeloid cells (Gr1+ and CD11b+) (G) and lymphoid cells (CD3+ and B220+) (H) and 
bone marrow cellularity (I). Plots represent the mean ± SE. Four mice were investigated per condition. n = 3. 
*p < 0.05, **p < 0.01 as determined by unpaired two-tailed student’s t-test.
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This result is unlikely to be a consequence of mutagenesis induced by VDJ rearrangements upon immune 
stimulation because there was no increase in double strand breaks in the lymphoid fraction of the bone marrow 
specifically (Fig. 6E). One possible explanation is that, although most of the intrauterine DNA damage would 
have been repaired or removed by 4 weeks postnatally, a small population of haematopoietic stem/progenitor 
cells has retained damage and these cells gained proliferative advantage upon activation with PolyI:C, passing on 
their DNA damage to progeny.
Damage to the stem/progenitor cell compartment. To test the hypothesis that DNA damage caused 
by benzene-induced placental signalling is retained in stem/progenitor cells, we further characterised the damage 
in CD34+ cord blood cells after in vitro exposure and in various lineages of the mouse haematopoietic system after 
in vivo exposure. It has been shown that human leukaemia-initiating cells are often found within the CD34+ frac-
tion36–38. For this reason, CD34+ cells were enriched by fluorescence activated cell sorting (FACS) after a 24 hour 
exposure to BeWo CM from BQ + HQ exposure. Metaphase spreads of CD34+ cells displayed a remarkable 
increase in predominantly hypodiploid, but also hyperdiploid, metaphases after exposure to the collected media 
compared to controls, at the expense of euploid cells (Fig. 6A). Furthermore, it was shown that proliferating (Ki-
67+) CD34+ cells are especially sensitive to damage induced by BeWo CM after benzene exposure, shown by a 
significant increase in γ-H2AX positive cells in the proliferating CD34+ but not CD34− compartment (Fig. 6B). 
Despite CD34+ cells harbouring such damage, their colony forming potential was not affected, suggesting that 
multi-lineage clonogenic potential is retained (Fig. 6C).
To test whether HQ treatment in vivo had resulted in the accumulation of DNA damage in the HSC pool of 
the offspring, which is then expanded during stress-induced HSC proliferation, with the DNA damage being 
passed on to the progeny, we employed an in vitro assay for inflammatory stress-induced HSC proliferation, using 
interleukin-1 (IL-1) as a pro-inflammatory signal39. This assay involves culturing purified mouse HSCs (Lin−/
Sca1+/ckit+/Flk2−/CD48−/CD150+) in the presence of IL-1, which induces HSC proliferation and differentiaton 
towards the myeloid lineage. Pregnant females were again treated with either H2O (vehicle) or HQ at GD12 and 
the bone marrow of the pups was harvested at 4 weeks of age. HSCs were then isolated by FACS and grown in 
culture for 8 days in the presence of IL-1. At the end of the culture, the cells were spotted on slides and stained 
for γ-H2AX foci (Fig. 6D). The results revealed a highly significant increase of DNA damage in the cells from 
HQ-treated mice, demonstrating that HSCs from the offspring of HQ-treated mothers had indeed retained DNA 
damage in their HSC population which is maintained upon proliferation and differentiation following an inflam-
matory response. The bone marrow of pups harvested at 4 weeks postnatally and after polyI:C treatment also 
showed increase in DNA damage in the myeloid compartment if mothers were exposed to HQ (Fig. 6E). It cannot 
be deduced from the in vivo data, however, if this DNA damage occured in mature myeloid cells or whether the 
damage is inherited from stem/progenitor cells through proliferation and differentiation.
Cellular distributions. FACS analyses revealed that there was no significant increase in bone marrow cellu-
larity (Fig. 6I) and in the size of the myeloid (Gr1+ and CD11b+) and lymphoid (CD3+ and B220+) compartments 
(Fig. 6G,H, respectively) in the bone marrow of the 4 week old offspring, after maternal HQ exposure in vivo. This 
is consistent with the observation that the size of the HSC pool in the offspring was not affected by maternal HQ 
treatment (Fig. 6F).
The bone marrows were also examined with histology and cytology. All bone marrows in paraffin sections, 
both experimental and control, were markedly hypercellular at this age, with predominat hyperplasia in the mye-
loid and megakaryocyte lineages (Fig. S8A–D). Only minor morphological differences were seen in vivo between 
experimental and control samples; the megakaryocytes were more hyperlobulated in experimental marrows than 
in control. After hydroquinone treatment, without PolyI:C, there were fewer erythroid islands and scattered mye-
loblasts compared to the other marrows. No small B cells (CD20+) were seen although a small number were 
present in control and other experimental marrows. After PolyI:C treatment, there were scattered myeloblasts and 
an increase of T cells (CD3+) from 1% to 5%. The bone marrow aspirates were also hyperplastic with a left shifted 
myeloid lineage (Fig. S8E,F). This was more noticeable in experimental aspirates compared to control. In con-
clusion, the in vivo exposed bone marrow cells appear to behave in a similar manner to the in vitro exposed cord 
blood. Despite the increase in DNA damage, there is little evidence that the exposures caused a profound shift 
in proliferation or differentiation capacity. This is in line with our hypothesis because presence of pre-leukaemic 
mutations alone is not sufficient to alter stem/progenitor cell behaviour. This is evident by the large proportion 
of healthy people harbouring ETV6/RUNX1 fusion genes in their haematopoietic cells, without ever develop-
ing haematological malignancy. Only 1% of people carrying initiating mutations develop overt leukaemia, after 
encountering a secondary hit during a window of susceptibility40.
Discussion
In this paper, we have set out to examine whether there is any evidence that in utero damage to haematopoietic 
cells could be caused by the placenta releasing factors in response to suspected leukaemia-initiating maternal 
exposures. We have noted previously that trophoblast barriers can release factors that cause DNA damage in 
human embryonic stem cells22,41 and human fibroblasts23,25 when the barriers have been exposed to agents that 
cause oxidative stress. We have also noted that this can be prevented by applying a soluble antioxidant (MitoQ) 
to the barrier or an agent that impairs cell-to-cell signalling within the bilayered trophoblast barrier23,25. In more 
recent experiments, we have also noted that an application of soluble MitoQ in vitro or an intravenous injection of 
MitoQ bound to nanoparticles in vivo (that enter into trophoblasts but do not reach the foetus)35 can prevent the 
placenta from releasing various factors, including those that can damage brain cells and prevent postnatal damage 
to the heart and brain (56, 57, 60). We therefore reasoned that a similar type of damaging communication might 
occur between the trophoblast and the foetal blood within the placental villi.
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We have found it necessary to use three models, an in vitro model, an ex vivo model and an in vivo model as 
each model has its own advantages and disadvantages42. The in vitro model of BeWo cells allows a bilayered bar-
rier of trophoblasts to be exposed in a polarized manner in keeping with in vivo exposure. Studies have reported 
considerable likeliness between BeWo cells and primary human trophoblast, with regards to architecture, secre-
tions and receptor expression43–45. It is, however, comprised of a choriocarcinoma cell line. The ex vivo model 
allows the placenta to be exposed in vivo and has the correct architecture and cellular composition of the in vivo 
placenta but it is not possible to be certain here from which surface or cell type the DNA damaging signals might 
be sent. The in vivo model allows in vivo exposures to be made in a polarized fashion but here it is difficult to be 
certain that some exposures to the placenta, especially radiation, would not also expose the foetus. We have there-
fore employed all three models and drawn conclusions from each. Our in vitro model allows us to conclude that 
bilayered trophoblast barriers respond in the same way to the agents that are associated with increased risk of leu-
kaemia as they did to previously studied insults22,23,25,26,35. After exposures on the top surface of the barrier, factors 
are released from the bottom surface of the barrier, which cause DNA strand breaks and chromosome aberrations 
in haematopoietic cells including stem/progenitor cells. As in the previous experiments23,25, the damage was pre-
vented by treatment of the barrier with an antioxidant. It is interesting with regard to our hypothesis that the cord 
blood cells were selective in their response, compared to fibroblasts, and were only damaged by agents that have 
been strongly linked epidemiologically to an increased risk of leukaemia (see introduction).
Because the barrier in vitro and ex vivo released factors that caused DNA damage after exposure to a 
non-chemical agent, i.e. altered oxygen and X-irradiation, we can be confident that in these cases the barrier 
is releasing the DNA damaging agent and that there is no possibility of an exposing chemical passing through 
the barrier to cause direct damage to the cells on the other side. In the case of exposure to benzene metabolites, 
we found no evidence of the exposing chemical in the conditioned media and there was no change in barrier 
integrity (Figs S2, S3). This strengthens our original hypothesis23 that the placental trophoblast barrier can send 
a bystander-like signal to cause DNA damage in a neighbouring cell in a similar fashion to the radiation-induced 
bystander effect, where the receipt and emission of the signal is dependant on mitochondrial oxidative stress 
and where the effect can be noted in vitro and in vivo46–49. The prevention of this damage by the mitochondrial 
targeted antioxidant, which also prevents damage to heart and brain35,50, also strengthens this idea. The nature of 
the radiation-induced bystander signal is not known and several molecules have been implied47. The evidence in 
this paper also suggests that several molecules might be released from the barriers and that cord blood cells might 
be potentially sensitive to only some/one of them, which could explain their selective response. According to our 
hypothesis of bystander-like barrier signalling, it could also provide an explanation for why leukaemia is only 
caused by certain epidemiological agents.
As in our previous experiments, the characteristics of the in vitro or ex vivo barrier signalling were paralleled 
by the changes that were noted in an in vivo model. The in vitro experiments resulted in DNA double strand 
breaks, DNA cross-links and aneuploidy in the cells that were exposed to the conditioned media. As discussed, 
aneuploidy is the most prevalent karyotypic abnormality in cALL, followed by ETV6/RUNX1 fusion and other 
specific fusion events. Although these initiating mutations give rise to leukaemias with different clinical prog-
noses, they act similarly to one another in the sense that a single prenatal event is sufficient to render a cell 
pre-leukaemic, with leukaemia occuring in selected cases upon encounter of a secondary hit. Furthermore, there 
was evidence of damage to stem/progenitor cells without altering the differentiation capacity and whilst main-
taining clonogenic potential. A similar behaviour is expected from pre-leukaemic cells that display grossly normal 
behaviour until a second hit is encountered. This process appeared to be prevented by antioxidant treatment 
using N-acetyl cysteine. The in vivo experiments also showed DNA double strand breaks and increased DNA 
cross-links in foetal bone marrow, with no marked change in the cellular compartments in the bone marrow, and 
again with evidence that this process might be prevented by treatment with an antioxidant.
We demonstrate some characteristics of a carcinogenic-like process with DNA damage, chromosome aberra-
tions and damage to the stem/progenitor cell compartment. It would be of interest to determine in future exper-
iments whether dysplastic or malignant changes would be observed in the longer term following injection with 
PolyI:C. What we have seen is a potential two-hit type of mechanism in which much of the DNA damage that 
occurred after a single in utero exposure was seemingly repaired by 4 weeks postnatally but where there was still 
residual damage, most likely concentrated in cells with clonogenic capacity, that was able to result in significant 
DNA damage when a viral immune stimulus or a stress stimulus, which causes proliferation of stem/progenitor 
cells, was encountered. Our observation of ‘trans-generational’ DNA damage therefore does mirror our current 
understanding of the two-hit hypothesis for childhood leukaemia.
Although the overall cure rate for paediatric acute leukaemia is high51,52, treatment can cause severe and 
long-term side effects, and certain subtypes remain troubled by poor prognosis53,54. Greater understanding of the 
disease aetiology is essential for paving the way to novel treatments or earlier intervention. The model described 
here can act as a useful tool in this endeavour and could be relevant to study other common leukaemia-initiating 
events, such as ETV6/RUNX1 and MLL fusion events. Should the type of process that we describe here prove 
to be of clinical relevance, there is a possibility that this damaging sequence might be potentially preventable 
through a strategic treatment with an antioxidant.
Methods
Chemicals. Chemicals were used at the following concentrations unless otherwise stated: HQ, 30 µM (Sigma-
Aldrich, UK), BQ, 30 µM (Sigma-Aldrich), N-Acetyl-L-cysteine, 10 mM (Sigma-Aldrich), MitoQ, 0.5 mM 
(gift from M. Murphy, Antipodean Pharmaceuticals Inc.), Hexavalent Chromium ions, 0.4 µM (eCrater, UK), 
Polyinosinic–polycytidylic acid (Poly I:C), 2.5 ng/ml to 25 µg/ml (Sigma-Aldrich), Lipopolysaccharides (LPS), 
0.02 ng/ml to 200 ng/ml (Sigma-Aldrich), epicatechin, 2 ng/ml to 20 ug/ml, quercetin, 100 nM to 100 µM 
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(Sigma-Aldrich), etoposide, 100 nM to 100 µM (Sigma-Aldrich), pyrethroid standard mixture and piperonyl 
butoxide (pesticides), 1.3 µg/ml, 13 µg/ml, 130 µg/ml and 1300 µg/ml (Sigma-Aldrich).
Hypoxic exposures involved growing BeWo barriers in a modular incubator chamber (Billups-Rothenberg), 
flushed daily with 1% O2, 5% CO2 and N2 (balance), 37 °C for at least 4 min at a flow rate of 20 l min−1 and then 
sealed.
Nanoparticles. An amphiphilic copolymer of poly (γ-glutamic acid) and L-phenylalanine ethylester 
(γ-PGAPhe) was synthesized as previously described55 using a 50% Phe grafting degree. 10 mg/ml of γ-PGA-Phe 
was dissolved in DMSO, added to equivalent volume of 0.15 M NaCl and dialyzed against distilled water. The 
dialyzed solutions were freeze-dried and resuspended in PBS (10 mg/ml). NPs were measured by dynamic light 
scattering (Zetasizer Nano ZS, Malvern Instruments, UK) as 180 nm diameter, polydispersity index 0.12, Zeta 
potential −20 mV.
γ-PGA-Phe NPs (10 mg/ml) were mixed with MitoQ (2 mg/ml) at equivalent volume in 0.2 M NaCl and incu-
bated at 4 °C for 12 h. NPs were isolated by centrifugation, washed with PBS, and resuspended in PBS to 10 mg/ml.
Cell culture. BeWo b30 cells were obtained from the University of Bristol (Dr Margaret Saunders) and cul-
tured in Dulbecco’s modified eagle’s medium (DMEM) nutrient mixture F-12 Ham with phenol red, supple-
mented with 1% L-glutamine-penicillin- streptomycin (PSLG), 1% amphotericin B solution (AmpB) and 10% 
foetal bovine serum (FBS, Sigma-Aldrich) at 37 °C in 5% CO2. The cells were seeded at 1.12 × 105 cells on polyes-
ter 0.4-mm-pore membranes in a transwell plate and grown as a barrier with regular medium change for 7 days.
Human umbilical cord units were obtained from NHS Cord Blood Bank, NHS Blood and Transplant (Filton, 
UK) with North Bristol research ethics committee approval and with informed patient consent. All methods were 
performed in accordance with the relevant guidelines and regulations. Mononuclear cells were obtained by Ficoll 
gradient centrifugation and red blood cells (RBC) were depleted using RBC lysis solution (Miltenyi Biotec, Bisley 
UK). The cells were maintained in Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with 10% FBS, 
1% penicillin- streptomycin (Sigma) and 1% Glutamax at 5% O2, 5% CO2, 37 °C. For CD34 expansion culture, 
cytokines IL-3, G-CSF, TPO, IL-6, Flt3, SCF (in StemSpan SFEM media (STEMCELL Technologies, Cambridge, 
UK)) were added to the culture to maintain proliferation.
Primary BJ human fibroblasts were obtained from the American Type Culture Collection (ATCC) and main-
tained in minimal essential medium (Sigma-Aldrich) supplemented with 10% FBS (Invitrogen), 2% HEPES 
buffer (Sigma-Aldrich), 1% sodium pyruvate solution (Sigma-Aldrich), 1% penicillin- streptomycin solution and 
1% L-glutamine (Sigma-Aldrich) at 5% O2, 5% CO2, 37 °C.
For the ex vivo stress-induced proliferation assay, 500 bone marrow HSCs (Lin−/Sca1+/ckit+/Flk2−/CD48−/
CD150+), sorted independently from 3 pups whose mother had received vehicle (H2O) and from 3 pups whose 
mother had received HQ, were plated in StemPro34 (Invitrogen) containing Pen/Strep (50 U/ml), L-glutamine 
(2 mM), SCF (25 ng/ml), Flt3L (25 ng/ml), IL11 (25 ng/ml), IL3 (10 ng/ml), GM-CSF (10 ng/ml), Epo (4 IU/ml), 
Tpo (25 ng/ml) and IL1b (25 ng/ml). They were incubated at 37° in 5%CO2 for 8 days and 30% of the medium 
refreshed every other day.
Measurement of DNA damage. DNA damage was measured using either quantitative immunocytochem-
istry (Q-ICH), the alkaline comet assay or Image stream.
Quantitative immunocytochemistry. A panel of markers of DNA damage and repair was used which 
was comprised of antibodies against γ-H2AX; 53BP1 (Life Technologies, UK) (DNA double-strand break (DSB), 
FANCD2 (interstrand crosslinks (ICL), Ku70/Ku80 (non-homologous end joining (NHEJ)), RPA32 (gift from Dr. 
Abderrahmane Kaidi) (Homologous recombination (HR)) and XRCC1 (Single strand break (SSB)). All primary 
antibodies were purchased from Source Bioscience, USA unless otherwise stated. The fibroblasts were fixed over 
10 min at room temperature (RT) in 2% paraformaldehyde (Sigma-Aldrich), washed in PBS and permeabilized 
over 10 min in 0.2% Triton (Sigma-Aldrich), washed twice in PBS, and blocked over 1 hr using 150 ml of PBS 
and 10% Bovine serum albumin (BSA) (Life Technologies,). Cells were stained overnight at 4 °C in 100 µl of 
primary antibody solution in PBS and BSA with the following concentrations: γ-H2AX (1:1000); 53BP1 (1:500), 
FANCD2 (1:500), Ku70/Ku80 (1:250), RPA32 (1:500) and XRCC1 (1:250). After cells were washed twice in PBS, 
60 µl of secondary antibody solution (goat anti-rabbit IgG or donkey anti-goat IgG or Goat Anti–Mouse IgG) (Life 
Technologies) was added over 2 hrs at RT in the dark in PBS and BSA with the 1:500 concentration.
UCB and bone marrow cells-grown on polylysine (Sigma-Aldrich)-coated coverslips-were fixed over 10 min 
at room temperature (RT) in 2% paraformaldehyde, washed in PBS and incubated overnight in a humidified 
chamber at RT. Cells were then permeabilized over 10 min in 0.2% Triton, washed twice in PBS, and blocked over 
1 hr using 150 ml of PBS and 10% Goat Serum (Life Technologies). Cells were stained overnight at 4 °C in primary 
antibody solution in PBS and goat serum with the concentrations as described above. After cells were washed 
twice in PBS, secondary antibody solution (goat anti-rabbit IgG or donkey anti-goat IgG or goat anti–mouse IgG) 
was added over 2 hrs at RT in the dark in PBS and goat serum with the 1:500 concentration.
Slides were visualized under widefield microscope. All microscopy images were captured using 100X 
oil-immersion objective and images were processed with Volocity software. Analysis was performed by counting 
the number of foci in 100 nuclei of each slide. Results were expressed as the average number of foci in each cell. 
For DNA damage distribution analysis, 100 cells were counted and cells were divided according to the number of 
foci per cells. Three slides per condition were analysed.
Alkaline comet assay. The alkaline comet assay was performed according to previous protocols56,57. Cells 
with or without H2O2 treatment, were suspended in low melting point agarose in PBS, pH 7.4, at 37 °C and 
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pipetted onto a frosted glass microscope slide pre-coated with 3 layers of agarose. The agarose was allowed to set 
at RT for 30 min and the slide immersed in lysis solution (2.5 M NaCl, 100 mM Na EDTA, 10 mM Tris, NaOH to 
pH 10.0, and 1% Triton X-100) at 4 °C for 1 h to remove cellular proteins. Slides were then placed in a single row 
in a 260 mm wide electrophoresis tank containing 0.3 M NaOH and 1 mM Na EDTA for 40 min, before electro-
phoresis at 40 V, 300 mA, for 30 min at an ambient temperature of 4 °C (the temperature of the running buffer 
not exceeding 15 °C). The slides were then washed 3 times for 5 min each dH2O, pH 7.5, at 4 °C before staining 
with 5 pg/ml ethidium bromide. Electrophoresis was performed at 4 °C in light-controlled conditions. A total of 
300 cells with wells set up in triplicate for each treatment were scored at 400X magnification using a fluorescence 
microscope (Olympus BX-50) with an excitation filter of 515–560 nm and barrier filter of 590 nm and image anal-
ysis software (COMET III, Perceptive Instruments). DNA damage was evaluated by the tail moment (product of 
comet length and tail intensity). Fibroblasts were plated at 5 × 104 per well into 12-well plates (Orange Scientific) 
and on round 18 mm glass coverslips for γ-H2AX assay, fixed in 4% formaldehyde and immunostained with 
polyclonal antibody to histone H2AX and donkey anti-rabbit IgG, secondary antibody. One hundred cells per 
well were scored in triplicate using an Olympus BX-41 microscope with image analysis software. The mean tail 
moment value is the mean of the comet tail of 100 cells. The average of the means of the 3 replicates is displayed. 
UCB cells were cultured in suspension in 12-well pates at 5 × 104–1 × 106 cells per well.
BeWo barrier integrity measurement. Barrier integrity was checked using trans-epithelial electrical 
resistance (TEER) measurements and FITC- dextrans memberane permeability assay according to previous 
methods (77).
Image stream. The Image Stream IS100 (Merck) equipped with 3 lasers (violet 405 nm, blue 488 nm and red 
658 nm) and halogen lamp was used at the Nuffield Department of Medicine, University of Oxford. Antibody 
titration occurred prior to sample staining for all antibodies. UCB-MNCs were exposed indirectly to 30 μM HQ 
and BQ across bilayered cell barriers of BeWo cell line for 24 hours. Positive controls and single-stained ɣ-H2AX 
controls were subjected to 2 Gy X-ray radiation (Nuffield Department of Clinical Laboratory Sciences, John 
Radcliffe hospital, Oxford) 30 minutes prior to cell staining. Cells were washed in FC buffer (Hanks + 2% HAS) 
prior to staining. Staining occurred in 96 well round bottom plates (Corning) and centrifugation occurred at a 
speed of 500 × g for 5 minutes at 4 °C. Cells were washed and stained with combinations of the following cell sur-
face antibodies: anti-human CD34-PE, anti-human CD38-APC/FITC (BD), anti-human CD3-APC, anti-human 
CD19-PE (eBioscience, Loughborough, UK), anti-human lineage cocktail-PB (CD3, CD14, CD16, CD19, CD20, 
CD56) (Biolegend, London, UK), for 25 min at RT on a shaker. Foxp3 transcription factor staining buffer kit was 
used (eBioscience). Cells were washed twice in FC buffer, fixed in 100 μL fixation buffer (eBioscience) for 15 min-
utes at room temperature on a shaker, washed twice in permeabilisation buffer and incubated with anti-human 
γ-H2AX-FITC (eBioscience) antibody for 20 minutes at RT on a shaker. After washing twice in FC buffer, cells 
were then re-suspendeded in 70 μL FC buffer and transferred to a 500 μL Eppendorf tube and kept in the dark 
until flow cytometric analysis. A minimum of 104 focused live cells were collected per sample. Data was analysed 
using Amnis software (IDEAS). Single stained samples were used to create a compensation matrix. A data acqui-
sition template was created and applied to each sample. This was firstly to identify live, in focus single cells based 
on autofluorescence in all channels, cell morphology (brightfield channel) and FSC-SSC parameters. Cell popu-
lations of interest were then identified by fluorescence intensity and relative quantification of y-H2AX calculated 
by utilising the IDEAS spot count analysis feature to determine the number of γ-H2AX foci/cell.
Flow cytometry and cell sorting. A MACSQuant Analyser 10 (Miltenyi Biotec) or a LSR Fortessa (BD BD 
Biosciences) were used for flow cytometric analysis. Antibody labelling was carried out for 30–45 minutes at 4 °C. 
Propridium iodide (PI, BD Biosciences) or SYTOX Dead Cell Stains (Life Technologies) was added as a viability 
dye prior to analysis. Compensation was performed with single antibody-stained beads and for each antibody, an 
isotype control and a Fluorescence-Minus-One control was prepared in the same way as the samples. Data was 
analysed using FlowJo software (V10.0.07).
Cell sorting was performed on a BD Influx high speed machine or an ARIA cell sorter. Human MNCs 
were washed in FACS buffer (Pre-Sort Buffer (BD Biosciences) supplemented with 100 ug/ml DNase-II 
(Sigma-Aldrich) twice and stained with CD34-APC (eBioscience). A minimum of 105 unsorted cells and CD34− 
cells and between 5 × 102 and 3 × 105 CD34+ cells were collected per sample. Murine myeloid bone marrow 
cells were sorted on the basis of Gr1 and CD11b expression and lymphoid cells on the basis of CD3 and B220 
expression. For the sorting of murine HSCs, red cell lysis buffer (STEMCELL Technologies) treated cells were 
first lineage-depleted using a Mouse Hematopoietic Progenitor Cell Enrichment Kit (STEMCELL Technologies). 
For further purification, a lineage cocktail (CD3e-APC, Ter119-APC, F4/80-APC, Nk1.1-APC, Gr1-APC, 
CD11b-APC, B220-APC, CD19-APC) was included in the antibody panel. The cells were further stained with 
Flk2-PE, Sca1-PB, ckit-APCeF780, CD48-FITC and CD150-PECy7 and Lin−/Sca1+/ckit+/Flk2−/CD48−/CD150+ 
HSCs were sorted.
Cytogenetics. Metaphase studies, using an equal volume and dilution of each cell suspension, were car-
ried out on SuperFrost slides fixed in Carnoy’s fixative (3:1 methanol: acetic acid). Slides were stained with 10% 
GIEMSA (Thermo Scientific) in dH2O for 15 min at room temperature. Numerical and structural chromosomal 
aberrations were scored in 100 metaphase spreads per experiment using a brightfield microscope DMLB2 (Leica) 
equiped with Colour DCF 450 C camera (Leica) or a fluororescent microscope A1AX10 (Zeiss) equipped with 
monochrome Retiga 300 camera (Q-imaging) using a 100x oil immersion lens. Images were scored using Image-J 
software. A mitotic rate was calculated as the number of mataphases per slide
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In vitro. All indirect exposures of cells to chemicals were made across bilayered cell barriers of the human 
trophoblast choriocarcinoma-derived BeWo cell line. BeWo barriers were grown on transwell inserts (pore size, 
0.4 mm). Chemicals (HQ + BQ, N-Acetyl-L-cysteine, hexavalent Chromium ions, PolyI:C, LPS, Epicatechin, 
quercetin, etoposide, pyrethroid standard mixture, piperonyl butoxide) were placed in the top chamber. BeWo 
barriers were grown for up to 7 days to create predominantly bilayered barriers. Media with no chemical addi-
tions were used as controls. Primary BJ human fibroblasts and umbilical cord blood (UCB) cells were exposed 
to the condition media collected from the bottom of insert plates. In one experiment the cells were exposed to 
conditioned media with N-Acetyl-L-cysteine.
In vivo. All animal experiments were performed according to institutional guidelines, UK Home Office 
approved project licence and a local University of Edinburgh Ethical Committee. The specifics of the experiments 
were further approved by the University of Edinburgh Veterinary Scientific Services. Animals were maintained 
in 12 h light/dark cycles with free access to food and water. Female C57BL/6 mice were mated with male C57BL/6 
mice overnight and pregnant females were designated day 0.5 post-coitum (dpc) by the presence of a vaginal plug 
the next morning. HQ was administered orally by gavage (50 mg/kg body weight in H2O) at a volume of 10 ml/
kg on GD 12 and controls were treated with H2O only. γ-PGAPhe nanoparticles (70) bound to MitoQ (56) were 
resuspended in 100 µl PBS (334.5 ng/ml) to give a final and equivalent concentration of 0.5 µM of MitoQ in the 
peripheral blood and were administered intravenously into the tail vein in a single injection in one population 
of pregnant mice at GD 12. Controls were injected with PBS only. For each experimental group, four mice were 
analysed. Total bone marrow samples from newborn foetuses were cultured in RPMI medium supplemented with 
10% FBS, 1% penicillin- streptomycin and 1% L-glutamine at 5% O2, 5% CO2, 37 °C. Some newborns were left to 
be weaned and the immunostimulant polyI:C was injected intraperitoneally (IP) at 4-weeks of age (5 mg/kg) as an 
infective mimic to simulate viral infections. Total bone marrow (BM) of the newborn mice was analysed for DNA 
damage. All bone marrow cells in this study were extracted from the femurs and tibiae of the mice.
Ex vivo. To investigate the effect of radiation-induced bystander mechanism, adult female C57BL/6J mice at 
GD12 were exposed to a whole body exposure 100 mGy or 1 Gy X-irradiation (AGO, United Kingdom, dose rate 
0.5 Gy/min (250 kVp and 13 mA)). All animals were bred and handled according to the UK Animals (Scientific 
Procedures) Act, 1986, Amendment Regulations 2012, and animal experimental protocols were reviewed 
and approved by the PHE CRCE Ethics Committee and the Home Office. The placentae were removed 4 hrs 
post-irradiation and cultured in RPMI medium supplemented with 10% FBS, 1% penicillin- streptomycin and 1% 
L-glutamine with 3 conditions: no drug additive, with MitoQ bound to NP (MQNP) (334.5 ng/ml nanoparticles, 
0.5 µM MitoQ) and with blank NP (BNP). Cultured explants were maintained in 5% O2 at 37 °C for 24 h. Total BM 
from age-matched female C57Bl/6J was exposed to conditioned media.
To investigate the effect of indirect (transplacental) exposure of mouse BM cells to HQ, total BM from 
age-matched female C57BL/6 mice was exposed to the conditioned media obtained from the explant placenta 
removed from mice at birth (GD18) that had been exposed to hydroquinone at GD12, 6 days earlier (see in vivo). 
The BM cells were cultured in RPMI medium in 5% O2 at 37 °C for 24 h.
statistics. Statistical analysis was performed using Prism 5.0 (GraphPad Software Inc.) and Microsoft Excel. 
Data are presented as mean ± SD (standard deviation). Where appropriate, parametric two-tailed student’s t-tests 
were applied to compare for significant differences between groups. When comparing more than 2 parameters, 
two-way ANOVAs (multiple independent groups) followed by Tukey post hoc testing (when p < 0.05) were 
performed.
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